Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
| Image |  |
|---|---|
| Description | scholarly article by A Keith Stewart et al published 4 February 2019 in Blood Cancer Journal |
| Author/s | |
| Publication date | February 4, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |